We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best quality stocks ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Billionaire investor Leon Cooperman in ...

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

These include white papers, government data, original reporting, and interviews with industry ... Early Stage Weight-Loss Drug Trial Results Eli Lilly Cuts Price of Weight-Loss Drug Zepbound ...

Eli Lilly is expanding the supply and cutting ... Get a brief on the top business stories of the week, plus CEO interviews, market updates, tech and money news that matters to you.

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...